82509-41-9 Usage
Description
(1S,4aS,6S,7S,7aS)-1-(beta-D-glucopyranosyloxy)-6-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid is a complex organic compound characterized by a hexahydrocyclopenta[c]pyran structure. It features a beta-D-glucopyranosyloxy group and a carboxylic acid functional group, along with a hydroxyl and a methyl group attached to the cyclopenta[c]pyran ring. This naturally occurring molecule is often found in certain plants or microorganisms and may possess potential pharmaceutical or biological activities. Its intricate structure makes it a subject of interest for further research and exploration.
Uses
Used in Pharmaceutical Industry:
(1S,4aS,6S,7S,7aS)-1-(beta-D-glucopyranosyloxy)-6-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid is used as a potential pharmaceutical agent for its possible biological activities. The presence of the beta-D-glucopyranosyloxy and carboxylic acid groups may contribute to its interaction with biological systems, offering potential therapeutic benefits that warrant further investigation.
Used in Research and Development:
In the field of organic chemistry and natural product research, (1S,4aS,6S,7S,7aS)-1-(beta-D-glucopyranosyloxy)-6-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid serves as a subject of interest for scientists. Its complex structure and natural occurrence make it a valuable compound for studying the properties of hexahydrocyclopenta[c]pyran derivatives and their potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 82509-41-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,5,0 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 82509-41:
(7*8)+(6*2)+(5*5)+(4*0)+(3*9)+(2*4)+(1*1)=129
129 % 10 = 9
So 82509-41-9 is a valid CAS Registry Number.
82509-41-9Relevant articles and documents
Algidisides I and II, New Iridoid Glycosides from Gentiana algida
Olennikov,Chirikova
, p. 637 - 641 (2016/09/03)
Two new iridoid glycosides, algidiside I [2′-(2′′,3′′-dihydroxybenzoyl)loganic acid] (1) and algidiside II [6′-(2′′,3′′-dihydroxybenzoyl)loganic acid] (2), and 14 known iridoids including for the first time from the aerial part of Gentiana algida Pall. 2′
Modified iridoid glycosides as anti-implantation agents: Inhibition of cell adhesion as an approach for developing pregnancy interceptive agents
Misra, Anju P.,Mathad, Vijayavitthal T.,Raj, Kanwal,Bhaduri, Amiya P.,Tiwari, Rashmi,Srivastava, Anuradha,Mehrotra
, p. 2763 - 2772 (2007/10/03)
Structural modifications in iridoid glycosides and evaluation of their efficacy on adhering capability (in vitro) of immature hamster uterine epithelial cells to the substratum have been studied. Out of 31, eight compounds in vitro, five compounds in utero and two in vivo showed adhesion/implantation preventing activity, respectively. The results provide an indication for further exploration in the line of development of anti-adhesive agents.
Iridoid glucosides from Picconia excelsa
Damtoft, Soren,Franzyk, Henrik,Jensen, Soren Rosendal
, p. 743 - 750 (2007/10/03)
An investigation of the iridoids of Picconia excelsa from Tenerife provided 17 iridoid glucosides together with verbascoside. Major constituents (> 0.5%) were loganin, ketologanin, oleoacteoside and the new picconioside I- a bisiridoid consisting of loganin esterified with deoxyloganin. Minor constituents were secoxyloganin, 8-epi-kingiside, oleoside 11-methyl ester, excelsioside, ligstroside and loganic acid together with the new compounds ketologanic acid, 6β-hydroxy-7-epi-loganin and picconiosides II-V, the latter four being esters of loganin and menthiafolic, foliamenthic, 6-(Z)- foliamenthic or 6,7-dihydrofoliamenthic acid. The structures were mainly elucidated by NMR spectroscopy.
